Answers are grounded in this paper and cite their sources.
INTRODUCTION: The origin, isolation, and characterization of (Z)-isopropyl 7-((1R, 2R, 3R, 5S)-2-((1E, 3Z)-3-fluoro-4-phenoxybuta-1, 3-dienyl)-3, 5-dihydroxycyclopentyl) hept-5-enoate, an impurity found in the preparation of an anti-glaucoma agent-Tafluprost has been described in this study. MATERIALS AND METHODS: Further, an enantiospecific synthesis of (Z)-isopropyl 7-((1R, 2R, 3R, 5S)-2-((1E, 3Z)- 3-fluoro-4-phenoxybuta-1, 3-dienyl)-3, 5-dihydroxycyclopentyl) hept-5-enoate has been revealed using deoxofluorination as a key transformation of the strategy. RESULTS AND DISCUSSIONS: Moreover, the impurity showing anti-glaucoma properties in docking studies with respect to bimatoprost has been described. CONCLUSION: The extention of our work towards docking studies and the present impurity molecule showed almost the same biological activity with respect to Tafluprost.
No takes yet. Share an insight, caveat, or question.
Jaggavarapu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: